According to Marksans Pharma
's latest financial reports the company has $80.89 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $87.09 M | 90.5% |
2022-03-31 | $45.72 M | 60.26% |
2021-03-31 | $28.52 M | 131.01% |
2020-03-31 | $12.35 M | 160.99% |
2019-03-31 | $4.73 M | -22.43% |
2018-03-31 | $6.1 M | 57.78% |
2017-03-31 | $3.86 M | -26.73% |
2016-03-31 | $5.27 M | -82.2% |
2015-03-31 | $29.63 M | 277.78% |
2014-03-31 | $7.84 M | 168.16% |
2013-03-31 | $2.92 M | -33.52% |
2012-03-31 | $4.4 M | -36.51% |
2011-03-31 | $6.93 M | -12.53% |
2010-03-31 | $7.92 M | 80.11% |
2009-03-31 | $4.39 M | -71.5% |
2008-03-31 | $15.43 M | -57.99% |
2007-03-31 | $36.75 M | -17.18% |
2006-03-31 | $44.37 M | 1894.07% |
2005-03-31 | $2.22 M |